Home - Products - Others - Other Targets - Ninerafaxstat trihydrochloride

Ninerafaxstat trihydrochloride

CAS No. 2311824-72-1

Ninerafaxstat trihydrochloride( Ninerafaxstat trihydrochloride(2254741-41-6 Free base) )

Catalog No. M28893 CAS No. 2311824-72-1

Ninerafaxstat trihydrochloride shifts cellular metabolism to glucose oxidation from fatty acid oxidation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 267 Get Quote
10MG 439 Get Quote
25MG 860 Get Quote
50MG 1242 Get Quote
100MG 1674 Get Quote
500MG 3348 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ninerafaxstat trihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Ninerafaxstat trihydrochloride shifts cellular metabolism to glucose oxidation from fatty acid oxidation.
  • Description
    Ninerafaxstat trihydrochloride shifts cellular metabolism to glucose oxidation from fatty acid oxidation. Ninerafaxstat trihydrochloride improves overall mitochondrial respiration and reduces fatty acid oxidation, thereby inhibiting the proliferation and growth of cancer cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Ninerafaxstat trihydrochloride(2254741-41-6 Free base)
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    AMPAR|AMPA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2311824-72-1
  • Formula Weight
    524.87
  • Molecular Formula
    C22H32Cl3N3O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 41.67 mg/mL (79.39 mM)
  • SMILES
    COC1=C(OC)C(OC)=C(CN2CCN(CC2)CCOC(C3=CN=CC=C3)=O)C=C1.Cl.Cl.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.O'Neill MJ, Witkin JM. AMPA receptor potentiators: application for depression and Parkinson's disease. Curr Drug Targets. 2007 May;8(5):603-20. Review.
molnova catalog
related products
  • Inbakicept

    Inbakicept (ALT 803) is a fusion protein of the IL-15 receptor α-sushi binding domain IL-15RαSu and immunoglobulin G1 (human Fc fragment), which is an IL-15 superagonist protein complex.

  • CPSI-1306

    (±)-CPSI-1306 is a macrophage migration inhibitory factor (MIF) antagonist and can be used in studies about non-insulin-dependent diabetes mellitus (NIDDM) and the prevention of the deleterious cutaneous effects of acute and chronic UVB exposure.

  • Caramel

    Caramel is a biochemical reagent that can be used as a biological material or organic compound for life science related research.